Introduction
It remains an unresolved question whether development of hematopoietic cells requires specific signaling pathways for differentiation or whether the differentiation program is predetermined and merely requires signals for cell survival for its expression (1) . B lymphopoiesis with the wealth of mouse strains with gain or loss of function mutations of key regulators of development serves as an ideal model system to resolve this issue.
B cell development occurs in the bone marrow by the orderly progression of precursor cells through a series of genetically and phenotypically defined stages of differentiation ( Fig. 1 ; reviewed in 2). The earliest committed B cell precursors can be identified by surface expression of the pan-B lymphocyte marker CD45R (B220) together with CD43 (S7) and c-Kit. Cells within this pro-B/pre-BI compartment (for nomenclature see 2) either possess unrearranged Ig heavy chain gene loci or D H -J H joinings only (3, 4) . Upon completion of a productive V H D H J H rearrangement pro-B/pre-BI cells progress to the early pre-BII stage, lose expression of CD43 and c-Kit, and the so-called pre-B receptor appears on the surface. This receptor complex is composed of an Ig µ heavy chain with the λ 5 and V pre-B surrogate light chains in association with mb-1 (Igα) and B29 (Igβ) co-receptors (5) . Large, cycling early pre-BII cells then become small, quiescent late pre-BII cells that commence Ig light chain gene (Igκ, Igλ) rearrangement. Virgin B cells, defined by expression of surface IgM (sIgM), are generated by productive rearrangement at one of the light chain gene loci. Those bearing highavidity self-antigen-specific receptors are eliminated in the bone marrow by a process termed activation-induced cell death (6, 7) . The remainder enter the periphery where a small fraction are selected by an unknown mechanism to become long-lived recirculating mature B cells, characterized by surface expression of IgM, IgD, CD21, CD22 and CD23 (8) (9) (10) .
Mice bearing mutations that preclude generation of productive Ig gene rearrangements show stage-specific blockages in B cell development. For example, the bone marrow of animals lacking either of the two recombinase activating genes, rag-1 or rag-2, contain only pro-B/pre-BI cells that lack any Ig heavy or light chain gene rearrangement (11, 12) . Mice homozygous for the scid mutation also are blocked at the pro-B/pre-BI stage. They do undergo very limited Ig gene rearrangement, albeit abnormally (13) (14) (15) . B lymphocytes lacking either the membrane spanning region of the Ig µ heavy chain (the so-called µMT mutation) or the Igβ co-receptor (B29) also fail to develop beyond the pro-B/ pre-BI stage, although a proportion of the B220 ϩ cells in µMT mice contains productive IgH gene rearrangements (16) (17) (18) . Analysis of such mutant mice provided compelling evidence that the pro-B/pre-BI to pre-BII transition is regulated by the rearrangement status of the IgH locus and requires surface expression of the pre-B cell receptor. Additional evidence for this notion comes from sequence analysis of the IgH gene loci of single cells from the pro-B/pre-BI and pre-BII stages, and from analysis of their expression of Ig µ heavy chains. These studies have shown that all cells in the pre-BII compartment contain cytoplasmic Ig µ protein; it derives from a single productive V (19) (20) (21) . This D H reading frame is the only one that has the potential to encode a truncated Ig µ-like protein, termed D µ , comprising the D H and J H segments fused to C µ (22) . It is thought that D µ surface expression interferes with B cell development at the pro-B/pre-BI to pre-BII transition, probably by inhibiting V H to D H J H gene rearrangement by a mechanism analogous to that used to impose allelic exclusion at the IgH locus (4, 19, 23) .
Clonal expansion of precursor B cells occurs at distinct stages of differentiation. Pro-B/pre-BI cell proliferation requires IL-7, stem cell factor and possibly other signals from stromal cells (24) (25) (26) . Cell division at the early pre-BII stage appears to be mediated by pre-B receptors (5, 27, 28) and presumably serves to increase the number of cells with productive IgH gene rearrangements which after growth arrest will undergo Ig light chain gene rearrangement. There is little proliferation among late pre-BII cells, virgin B cells and recirculating, mature B cells in the bone marrow (28) .
The lifespan of B cell progenitors is limited to~3 days in the absence of productive Ig gene rearrangement or surface Ig expression (29) . The size of the pro-B/pre-BI cell compartment of rag-1 -/-, rag-2 -/-, scid and µMT mice is similar to that of normal mice (11) (12) (13) . When an IgH transgene is introduced into rearrangement-deficient mice (rag-1 -/-, rag-2 -/-and scid), B cell development is arrested at the late pre-BII cell stage with no enlargement of that compartment compared to controls (30) (31) (32) . In all cases of developmental arrest described above, very few B cell precursors appear in peripheral lymphoid organs. Thus survival, differentiation and emigration of B cells from the bone marrow depend on surface Ig expression. In a previous study we reported that transgenic expression of the inhibitor of apoptosis Bcl-2 facilitated the appearance and accumulation of near normal numbers of sIg -B lineage cells in the peripheral blood and spleen of mice homozygous for the scid mutation (33) . Surprisingly, a significant fraction (~20-50%) of these B cells was found to express markers normally restricted to recirculating, mature B cells, such as CD21, CD22, CD23 and high levels of Ia (33) . One interpretation of these data is that the role of Ig molecules in B cell development is to provide a survival signal and that subsequent differentiation occurs spontaneously.
By comparing maturation of B cells in bcl-2 transgenic mice homozygous for either the scid, rag-1 -/-or µMT mutations we have explored further the role of Ig expression in B cell differentiation, and attempted to separate this role from effects on cell survival and proliferation. 
Methods

Mice
All mice were bred and maintained in specific pathogen-free conditions within the Walter and Eliza Hall Institute. The generation and characterization of the Eµ-bcl-2-36 (34) and Eµ-bcl-2-36/scid mice (33) have been described, as has the generation of rag-1 -/-mice (31) and µMT mice (16) , which were kindly provided by K. Rajewsky. Eµ-bcl-2-36/rag-1 -/-mice and Eµ-bcl-2-36/µMT mice were generated by serially crossing Eµ-bcl-2-36 (C57BL/6, N Ͼ 8) transgenic mice for two or more generations with rag-1 -/-(C57BL/6, N Ͼ 4) mice or µMT (C57BL/6, N Ͼ 4) mice. Inheritance of the bcl-2 transgene was determined by PCR as previously described (35) . Inheritance of the rag-1 knock-out allele was revealed by Southern blot analysis (31) . As µMT mice lack sIgM ϩ B cells (16) , homozygosity for this mutation was diagnosed by immunofluorescence staining (see below) of peripheral blood leukocytes with FITC-labeled anti-IgD antibody and phycoerythrin-conjugated anti-CD45R(B220) antibody (Caltag, South San Francisco, CA).
Cell preparation and immunofluorescence staining
Single-cell suspensions were prepared from bone marrow and spleen essentially as described (23) . Red blood cells were lysed using Tris-buffered ammonium chloride. All cell suspensions were filtered through nylon mesh to remove debris and clumps. Cells were stained with fluorochrome-or biotin-conjugated antibodies as previously described (36) . Antibodies used in this work were as follows: monoclonals 5.1 anti-IgM, RA3-6B2 anti-CD45R(B220), 7G6 anti-CD21, 2D6 anti-CD22, B3B4 anti-CD23, S7 anti-CD43, 187.1 antiIgκ light chain, JC5.1 anti-λ light chain, polyclonal sheep anti-mouse Ig (Caltag) and goat anti-mouse IgD (Nordic, Tilburg, The Netherlands). B cell subpopulations were isolated using a FACStar Plus cell sorter (Becton Dickinson, Mountain View, CA) after staining with fluorescence-labeled and biotinylated antibodies specific for the appropriate markers (as described in the text).
In vitro assays of cell differentiation
B lineage cells were purified by sorting from either the bone marrow or spleen of the indicated mouse strains. Ten thousand B cells of each phenotype were then cultured in the presence of IL-4, IL-5, FCS (10%), 2-mercaptoethanol and 5000 NIH 3T3 cells transfected with mouse CD40 ligand (37) . As a negative control, B cells were co-cultured with control NIH 3T3 cells plus IL-4 and IL-5. When proliferation was to be measured, the fibroblasts were irradiated with 30 Gy prior to the addition of B cells. Proliferation was determined by [ 3 H]thymidine incorporation during a 6 h pulse on day 3 of culture. The degree of proliferation was calculated as a stimulation index: SI ϭ (c.p.m. cultured with CD40 ligand NIH 3T3/c.p.m. cultured with control NIH 3T3). Ig secretion was determined after 7 days culture by quantitative ELISA assays on the supernatants using purified IgM and IgG1 myeloma proteins (Sigma, St Louis, MO) as standards.
Cell cycle measurements
The proportion of cells in the various phases of the cell cycle was determined by measuring the DNA content of nuclei isolated from sorted cells. Cells were stained for 30 min at 4°C with 50 µg/ml propidium iodide (Sigma) in 0.1% sodium acetate with 0.2% Triton X-100 (BDH Chemicals, Poole, UK) and then analyzed on a FACScan analyzer (Becton Dickinson). The CellFit program was used to calculate the percentages of cells in the various stages of the cycle.
Analysis of expression of transgene encoded Bcl-2 protein and cell survival assays
The intracellular levels of transgene encoded human Bcl-2 protein were determined as described (35) . Bone marrow cells were fixed for 10 min with 1% paraformaldehyde, stained with the mouse anti-human Bcl-2 mAb Bcl-2-100 (38) in the presence of 0.3% saponin, which was also included in all washing steps. Bound antibody was revealed with FITCconjugated sheep anti-mouse IgG (Caltag). MOPC 21 (Sigma) was used as an irrelevant mouse IgG antibody in these stainings. Stained cells were analyzed using a FACScan (Becton Dickinson) and the data processed using the software provided. Cell survival assays were performed on sorted B220 ϩ bone marrow cells from control mice, Eµ-bcl-2-36 transgenic mice, scid mice, Eµ-bcl-2-36/scid mice, rag-1 -/-mice, Eµ-bcl-2-36/rag-1 -/-mice, µMT mice and Eµ-bcl-2-36/ µMT mice. Ten thousand sorted cells were resuspended in 10 µl of the high glucose version of Dulbecco's modified Eagle's medium supplemented with 13 µM folic acid, 250 µM L-asparagine, 50 µM 2-mercaptoethanol and 10% fetal bovine serum, deposited into a single well of a Terasaki plate, and incubated at 37°C in 5% CO 2 . At regular intervals the fraction of viable cells was determined by visual inspection using phase contrast on an inverted microscope.
Cloning and sequencing of D H J H junctions
B220 ϩ CD23 ϩ and B220 ϩ CD23 -cells were isolated by cell sorting from the bone marrow of bcl-2/scid mice as described above, and genomic DNA was prepared as previously described (23) . D H J H junctions were amplified by PCR using the primers and protocol as described (23) . Rearrangements were cloned into pGEM5, recombinant plasmid DNAs were purified and directly sequenced using the M13 universal primer and the ABI PRISM sequencing kit (Applied Biosystems, Foster City, CA) according to the manufacturers protocol. The sequences were analyzed using an automated sequencer ABI 360.
Results
bcl-2 transgene expression promotes accumulation of B lymphocytes in scid, rag-1 -/-and µMT mutant mice
The ability of bcl-2 transgene expression to rescue B cells in mice homozygous for scid, rag-1 and µMT mutations was determined by enumerating B220 ϩ cells in the bone marrow and spleen. Without the transgene, B cell differentiation is Table 1. arrested at the pro-B/pre-BI stage in these mutant animals, and few B220 ϩ cells can be found in the bone marrow, peripheral blood and spleen (Fig. 2 , Table 1 and data not shown). As previously reported (33) , bcl-2 transgene expression resulted in the accumulation of near normal numbers of B220 ϩ cells in bone marrow, spleen and blood of bcl-2/scid mice ( Fig. 2 and Table 1 ). Similar accumulation of B lineage cells was observed in rag-1 -/-and µMT mice expressing the 
Differentiation of B lymphoid cells occurs in bcl-2/scid and bcl-2/µMT but not in bcl-2/rag-1 -/-mice
The B lymphoid cells that had accumulated within the bone marrow, peripheral blood and spleen of bcl-2 transgenic scid, rag-1 -/-and µMT mice expressing the bcl-2 transgene were examined for differentiation beyond the pro-B/pre-BI stage by measuring the proportion of B220 ϩ cells that were CD43 -, CD21 ϩ , CD22 ϩ and CD23 ϩ . In scid, µMT and rag-1 -/-mice all bone marrow and splenic B220 ϩ cells expressed CD43 and none expressed CD21, CD22 or CD23 ( Fig. 3 and data not shown), consistent with previous reports (11, 12, 16, 39) . Expression of a bcl-2 transgene promoted maturation of some B220 ϩ cells to the CD21 ϩ CD22 ϩ CD23 ϩ stage in both scid and µMT mice but notably not in rag-1 -/-mice. The distribution of CD23 on bone marrow and spleen cells from control and transgenic mice has been used to exemplify this point (Fig. 3) . The proportion of mature cells was greater in bcl-2/scid mice than in bcl-2/µMT animals (20-40 versus 5-15% of all B220 ϩ cells). Differentiation was not due to rare cells generating productive IgM and IgL gene rearrangements since all B220 ϩ cells remained sIgM -as determined by immunofluorescence staining and flow cytometric analysis (Fig. 2) . The ability of B lineage cells from the various mutant mice to respond to mitogenic stimulation in vitro correlated with their cell surface marker profile. B cells from rag-1 -/-and bcl-2/rag-1 -/-mice did not proliferate and, as expected, did not secrete Ig upon co-culture with CD40 ligand-transfected NIH 3T3 fibroblasts (Table 2) . Similarly, immature B220 ϩ CD23 -B lineage cells from scid, bcl-2/scid, µMT and bcl-2/µMT mice also failed to respond (Table 2 ). In contrast, the more differentiated B220 ϩ CD23 ϩ B cells from bcl-2/scid and bcl-2/µMT mice proliferated and, in the case of the bcl-2/µMT cultures, they matured into antibody-secreting cells upon CD40 stimulation (Table 2) . Although some secreted Ig was detected in the supernatants of B220 ϩ CD23 -cultures from bcl-2 transgenic µMT mice, the level was~5-fold less than in the CD23 ϩ cultures. No IgM or IgG1 was secreted by either scid or rag-1 -/-B cells, irrespective of the presence of the bcl-2 transgene.
An additional indicator of the differentiation potential of B lineage cells in the various mutant strains was obtained by measuring serum Ig levels. As expected, no Ig of any isotype was detectable in serum from rag-1 -/-mice, irrespective of the presence or absence of the bcl-2 transgene (Fig. 4) . In contrast, two of the six scid samples had low but detectable levels of IgA, IgG3, IgG2b and IgG2a, and all scid mice showed low levels of IgM. These Igs presumably arise as a result of the known 'leakiness' of the scid mutation (40), although it did not extend to IgG1. The bcl-2 transgene did not significantly alter the frequency of serum Ig ϩ scid mice or the levels of Ig in the serum except for IgG2b which was present in all bcl-2/scid samples. The findings with the µMT samples were strikingly different: in the absence of a bcl-2 transgene, no Ig of any class (save occasional traces of IgM) was detectable whereas all sera from bcl-2/µMT mice contained IgA, IgG2b, IgG2a, IgG1 and IgM. The levels of each Ig isotype were consistently higher than in any of the other strains and approached those seen in normal mice. IgG3 was, however, undetectable in three bcl-2/µMT serum samples and was low in the other two (Fig. 4) .
In sum, these data demonstrate that the ability of Bcl-2 to promote further B cell differentiation was restricted to the two mutant strains in which rearrangement at the IgH locus can be initiated.
Maturation of B cells in the bone marrow of bcl-2/scid mice is not associated with extensive proliferation
Having observed differentiation beyond the pro-B/pre-BI stage in bcl-2 transgenic mutant scid and µMT mice, we wished to determine whether this was associated with proliferation, as would occur at the early pre-BII stage in normal animals. To this end we purified pro-B/pre-BI cells (B220 ϩ CD43 ϩ ) and the more mature B lymphoid cells (B220 ϩ CD43 -) from bone marrow of BALB/c mice, scid mice (pro-B/pre-BI cells only) and bcl-2/scid mice, and determined their cell cycle distribution by flow cytometry. The results (Table 3) showed that the more mature B lineage cells in bcl-2/scid mice were not proliferating to any measurable extent. This was in contrast to the equivalent B cell fraction in control animals, where 20% of cells were in the S, G 2 or M phase of (Fig. 5 ).
Collectively these results rule out the possibility that the observed differences in differentiation of B220 ϩ cells reflect differences in transgene expression. (45, 46) . To determine if sδ ϩ sµ -cells were present in bcl-2/µMT mice, spleen cells were examined for the presence of B220 ϩ cells expressing IgD on their surface. Such cells were indeed found and furthermore all were shown to express CD23 (Fig.  6) . No cells of this phenotype were found in control µMT mice. Thus, in bcl-2/µMT mice, a significant fraction of the CD23 ϩ subset of B220 ϩ cells expressed surface IgD (Fig. 6) ; the remaining CD23 ϩ cells presumably expressed more distal IgH isotypes. These results suggested that signaling via sIg receptors containing heavy chains other than µ can promote differentiation of pro-B/pre-BI cells. scid mice (Fig. 2 and 33) , we considered the possibility that their differentiation might have resulted from the presence of D µ -encoding D H J H rearrangements. A fraction of D H J H rearrangements in bcl-2/scid B220 ϩ cells might be joined in rf2 with sufficient coding sequence to generate a D µ polypeptide. To examine this possibility, B220 ϩ CD23 ϩ and B220 ϩ CD23 -cells were sorted from the bone marrow of bcl-2/scid mice, and D H J H rearrangements amplified by PCR from their genomic DNA. These junctions were recovered and individual clones sequenced ( Fig. 7 and Table 4 ). From the B220 ϩ CD23 -fraction we recovered D H J H junctions containing substantial deletions, often encompassing both the D H and J H elements. Where both the D H and J H elements were identifiable, they invariably encoded rf1 and rf3 junctions as has been observed for pre-BII cells, virgin B cells and mature B cells in normal animals (19, 20) . In striking contrast, 50% of the junctions recovered from the B220 ϩ CD23 ϩ cells of bcl-2/ scid mice could potentially encode a D µ protein; the remainder were in rf1, in rf3 or could not be assigned a reading frame due to extensive deletion of the D H or J H elements (Fig. 7 and Table 4) . Although the D H coding segment itself was sometimes deleted, the sequences remaining still contained the potential promoter, initiation codon, leader sequence and the J H splice donor necessary for proper RNA processing. The distribution of D H J H reading frames requires some comment. If B cell differentiation in bcl-2/scid mice is mediated by D µ expression, then we would expect every B220 ϩ CD23 ϩ cell to contain a rf2 D H J H junction while no B220 ϩ CD23 -cell should contain such a junction. If expression of the D µ protein triggered both differentiation and the cessation of further gene rearrangement at the IgH loci (23), then one would expect 56% of D H J H rearrangements in such a population to be rf2: three of nine from the first IgH locus to rearrange plus two of nine from the second. Our observations closely matched these expectations with 50% of D H J H junctions recovered from B220 ϩ CD23 ϩ cells being rf2, while none of nine such junctions from B220 ϩ CD23 -cells were rf2 (Table 3) .
Expression of surface Ig classes other than IgM promotes B cell differentiation in bcl-2/µMT mice
Expression of D µ protein may promote B cell differentiation in bcl-2/scid mice
Using currently available detection systems such as flow cytometry and immunoprecipitation we have been unable to reproducibly demonstrate a C µ -containing protein on the surface of the bone marrow B cell precursors in bcl-2/scid mice. This failure may reflect either the inherent difficulty in detecting D µ protein on the surface of pre-B cells ex vivo and/or the transient nature of its expression in bcl-2/scid mice. Although differentiation out of the pro-B/pre-BI compartment requires an Ig-mediated signal, persistence of the more mature phenotype may be independent of such a signal in the presence of transgenic BCL-2. Despite this, the genetic data provides evidence that differentiation of bcl-2/scid B cells is regulated by a receptor complex containing a D µ protein.
Discussion
B cell differentiation proceeds through a succession of genotypically and phenotypically identifiable stages, and is regulated by the interaction of several processes (47) . These include proliferation of clones with productive IgH gene rearrangements (28) , growth arrest at the point of IgL gene rearrangement, apoptosis of cells lacking sIg and positive selection of those with potentially useful antigen receptor specificities into the pool of long-lived mature, recirculating B lymphocytes (Fig. 1) . We wanted to determine whether differentiation requires active signaling via surface receptors containing IgH chains or is merely a consequence of sustained B cell survival. This was achieved by constructing novel strains of mice bearing mutations that block Ig gene rearrangement (scid, rag-1 -/-) or plasma membrane deposition of sIgM (µMT) and that express in their B cells a bcl-2 transgene to inhibit apoptosis. We found that over-expression of Bcl-2 was sufficient to allow a large fraction of B lymphoid cells to survive, emigrate from the bone marrow, and accumulate in peripheral lymphoid organs of bcl-2/rag-1 -/-, bcl-2/µMT and bcl-2/scid mice. The degree of rescue was similar in each of these strains ( Fig. 2 and Table 1 ). These strains differed, however, in whether or not the persisting cells underwent further differentiation in vivo as manifested by expression of markers characteristic of mature B cells. Such markers appeared on a subset of the B220 ϩ cells in the bone marrow and spleen of bcl-2/scid and bcl-2/µMT mice, but on none of the B220 ϩ cells in bcl-2/rag-1 -/-mice ( Fig. 3 and Table 1 ). Expression of the more differentiated cell surface marker phenotype correlated with the capacity to respond to mitogenic stimulation in vitro ( 
Implications for the normal function of the pre-B receptor
Despite the differentiation of B cell precursors beyond the pro-B/pre-BI stage in bcl-2/scid and bcl-2/µMT mice, no proliferation was apparent among the more mature cells (Table 2 ). In contrast, normal B cells undergo an estimated four to six divisions at the early pre-BII stage (28, 29 (5), it is still unclear whether a specific ligand exists or whether receptor assembly alone is sufficient to trigger proliferation. In either case, it appears that the forms of pre-B receptor expressed in bcl-2/scid and bcl-2/µMT mice (presumably D µ , λ 5 , V pre-B and δ, λ 5 , V pre-B respectively) can only induce differentiation; they are insufficient to trigger proliferation. Pre-B receptor-mediated differentiation and proliferation can thus be dissociated, providing evidence that they are regulated by distinct signaling routes.
Implications for the fate of D µ protein-expressing B cell precursors in normal mice
Our results provide evidence that continued B cell differentiation in bcl-2/scid mice is due to expression of a D µ protein receptor (Fig. 7) . We have also shown that the more mature bcl-2/scid B cells are quiescent (Table 3) . Taken together, these results provide insight into the fate of D µ -expressing B cell precursors in normal mice and may explain why cells bearing rf2 D H J H rearrangements are selectively under represented among B lymphocytes beyond the pro-B/pre-BI stage (4, 19, 20) . A normal pro-B/pre-BI cell bearing a rf2 D H J H rearrangement would receive a differentiation-inducing signal via a D µ -containing pre-B receptor similar to that transduced by a full-size µ-containing pre-B receptor. This signal would block further rearrangement at the IgH locus and the cell would enter the pre-BII stage. The normal fate of a pre-BII cell would be a period of rapid clonal expansion (an estimated four to six divisions) followed by growth arrest and initiation of Ig light chain gene rearrangement. If D µ -expressing B cells in wild-type animals behaved like the putative D µ -expressing cells in bcl-2/scid mice and failed to proliferate after entry into the pre-BII compartment, then they would simply be lost from the B cell repertoire by dilution. D µ -encoding rearrangements presumably also arise in scid pro-B cells but do not result in the appearance of a more mature B cell population.
The appearance of such a population would therefore appear to depend on the survival function of the bcl-2 transgene, suggesting that the D µ protein is unable to support the continued survival of B cell precursors because of either its signaling properties or its transient expression. This observation reinforces the role of continued signaling through the B cell receptor in B cell maturation (49) .
Implications for the regulation of IgD expression and IgD function
The continued differentiation of a fraction of the B cell precursors in bcl-2/µMT mice appears to be mediated by surface expression of IgD. This IgD presumably arises from splicing of the rearranged V H D H J H gene segment to the C δ exons contained on a mRNA precursor initiated at the normal V segment promoter. The V H D H J H -C δ transcript is very likely to be generated by alternate splicing since in IgH allotype heterozygous µMT ϩ/-mice, the targeted µ locus is not subject to allelic exclusion and the allotype of the 'included' IgD is the same as that of the targeted µ locus, suggesting a cisacting phenomenon (17 and our unpublished data). Irrespective of the mechanism by which the productive V H D H J H gene segment becomes attached to C δ , the resultant protein can mediate the differentiation of the B cell precursor. Previous work has established that expression of an IgD transgene can 'allelically exclude' the endogenous IgH loci, can trigger IgL gene rearrangement and can allow apparently normal phenotypic development to a state of antigen responsiveness (45, 46) . Data presented here confirm the ability of IgD to promote B cell differentiation, and furthermore imply that IgD can enable the remaining downstream steps of B cell activation such as Ig isotype switching and antibody secretion (Figs 4 and 6). A remarkable feature of the bcl-2/µMT mice is the regular production of all classes of circulating Ig except IgM and the T cell-independent isotype IgG3 (Fig. 4) . Moreover, sIgD ϩ B cells sorted from bcl-2/µMT mice undergo isotype switching in vitro upon stimulation with CD40 ligand and IL-4 (data not shown). Together these results suggest that the serum Ig in bcl-2/µMT mice is the result of T cell-dependent immune responses involving the sIg ϩ B cells. Other studies have shown that the T cell compartment in µMT mice is functional (50) and should thus be able to provide help to antigen-activated B cells. The low level of the T cell-independent isotype IgG3 in bcl-2/µMT mice has interesting implications for the ability of the Ig expressed on these cells to mediate all types of B cell activation. While the relatively low density of Ig molecules on the surface of bcl-2/µMT B cells may be responsible for their inability to mediate T cellindependent activation, our results may provide evidence that sIgM is essential for this process. Finally, the fact that a fraction of bcl-2/µMT B cells expresses sIgD implies that such expression is not dependent on prior surface expression of IgM.
General implications for cell differentiation
Our data demonstrate that inhibiting apoptosis is not sufficient to promote differentiation of B lineage cells, providing evidence that differentiation and cell survival are subject to distinct control. This interpretation is compatible with previous observations that Bcl-2 over-expression enhances survival but does not promote differentiation of T cell precursors that fail to undergo positive selection (51, 52) . In contrast to these conclusions, data from other experimental systems have been interpreted as supporting the hypothesis that control of differentiation of hematopoietic precursors is intrinsic to the cells and that continued differentiation is therefore a natural consequence of sustained cell survival (53) . In that model, signaling by external factors such as cytokines or colony stimulating factors functions merely to prevent apoptosis of precursor cells. This conclusion was based on the observation that over-expression of Bcl-2 facilitated both survival and differentiation in growth factor deprived cells of the FDC-P Mix cell line (53) . The exact relationship between this immortalized hematopoietic progenitor line and its normal counterpart, however, is unclear. While our results derive from the lymphoid rather than the myeloid lineage, they directly address the interdependence of cell survival and differentiation within normal cells in vivo. Our data from bcl-2/rag-1 -/-mice strongly support the view that cell survival alone is insufficient to promote differentiation of precursors. B cell differentiation requires specific signals which may well have an effect on cell survival, but this is distinct to their effect on cell maturation. In the case of B lymphocytes, the differentiationinducing signal requires surface expression of an Ig or Iglike protein. We speculate that, analogous to the function of antigen receptors in lymphocytes, receptors for colony stimulating factors could also trigger distinct signaling pathways for differentiation, proliferation and survival of myeloid and erythroid cells.
